Correlation Between Neurocrine Biosciences and Indivior PLC
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Indivior PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Indivior PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and Indivior PLC, you can compare the effects of market volatilities on Neurocrine Biosciences and Indivior PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Indivior PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Indivior PLC.
Diversification Opportunities for Neurocrine Biosciences and Indivior PLC
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Neurocrine and Indivior is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Indivior PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Indivior PLC and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Indivior PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Indivior PLC has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Indivior PLC go up and down completely randomly.
Pair Corralation between Neurocrine Biosciences and Indivior PLC
Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 3.58 times less return on investment than Indivior PLC. But when comparing it to its historical volatility, Neurocrine Biosciences is 1.36 times less risky than Indivior PLC. It trades about 0.05 of its potential returns per unit of risk. Indivior PLC is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 2,160 in Indivior PLC on August 31, 2024 and sell it today you would earn a total of 234.00 from holding Indivior PLC or generate 10.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 8.56% |
| Values | Daily Returns |
Neurocrine Biosciences vs. Indivior PLC
Performance |
| Timeline |
| Neurocrine Biosciences |
| Indivior PLC |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Neurocrine Biosciences and Indivior PLC Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurocrine Biosciences and Indivior PLC
The main advantage of trading using opposite Neurocrine Biosciences and Indivior PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Indivior PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indivior PLC will offset losses from the drop in Indivior PLC's long position.The idea behind Neurocrine Biosciences and Indivior PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Indivior PLC vs. Emergent Biosolutions | Indivior PLC vs. Hypera SA | Indivior PLC vs. YourWay Cannabis Brands | Indivior PLC vs. Cumberland Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |